Access to oral COVID‐19 antivirals in the community: are eligibility ...
The Medical Journal of Australia - 05 Jun 2023The TGA decision was based on data from two industry-sponsored trials:2 the MOVe-OUT3 and EPIC-HR4 trials for molnupiravir and nirmatrelvir/ritonavir ...